Cita APA

Nagarajah, J., Le, M., Knauf, J. A., Ferrandino, G., Montero-Conde, C., Pillarsetty, N., . . . Fagin, J. A. (2016). Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine.

Citación estilo Chicago

Nagarajah, James, et al. Sustained ERK Inhibition Maximizes Responses of BrafV600E Thyroid Cancers to Radioiodine. 2016.

Cita MLA

Nagarajah, James, et al. Sustained ERK Inhibition Maximizes Responses of BrafV600E Thyroid Cancers to Radioiodine. 2016.